BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6875280)

  • 1. HLA in familial Hodgkin's disease.
    Conte R; Lauria F; Zucchelli P
    J Immunogenet; 1983 Jun; 10(3):251-5. PubMed ID: 6875280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin's disease in siblings.
    Warrier RP; Cushing B; Das L; Philippart A
    Clin Pediatr (Phila); 1985 Mar; 24(3):172-3. PubMed ID: 3971646
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA in familial Hodgkin's disease. Results and a new hypothesis;
    Marshall WH; Barnard JM; Buehler SK; Crumley J; Larsen B
    Int J Cancer; 1977 Apr; 19(4):450-5. PubMed ID: 844915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subs.
    Hors J; Steinberg G; Andrieu JM; Jacquillat C; Minev M; Messerschmitt J; Malinvaud G; Fumeron F; Dausset J; Bernard J
    Eur J Cancer (1965); 1980 Jun; 16(6):809-15. PubMed ID: 7408930
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA antigens in familial Hodgkin's disease.
    Greene MH; McKeen EA; Li FP; Blattner WA; Fraumeni JF
    Int J Cancer; 1979 Jun; 23(6):777-80. PubMed ID: 468411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens in Hodgkin's disease of very long survival.
    Hornmark-Stenstam B; Landberg T; Löw B
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(4):283-8. PubMed ID: 717041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation of HLA antigens to prognosis in Hodgkin's disease].
    Prazák J; Chytrý P; Hermanská Z
    Vnitr Lek; 1991; 37(9-10):781-8. PubMed ID: 1771812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of HLA antigens in patients with Hodgkin's disease.
    Prazák J; Hermanská Z
    Eur J Haematol; 1989 Jul; 43(1):50-3. PubMed ID: 2788584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Hodgkin's lymphoma from the perspective of HLA.
    Sonmez M; Erkut N; Ucar F; Buruk K; Cobanoglu U; Bahce M; Ural AU
    Intern Med; 2010; 49(6):607-10. PubMed ID: 20228601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease in siblings: a family study.
    Perlin E; Levine PH; McCoy J; Dean J; Herberman R
    Oncology; 1976; 33(3):116-8. PubMed ID: 189264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Hodgkin's disease and the major histocompatibility complex.
    Bowers TK; Moldow CF; Bloomfield CD; Yunis EJ
    Vox Sang; 1977; 33(5):273-7. PubMed ID: 144365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does the presence of HLA-B5 and B35 antigen signify a worse prognosis for Hodgkin's disease? Preliminary report].
    Prazák J; Hermanská Z
    Vnitr Lek; 1988 Mar; 34(3):270-6. PubMed ID: 3259347
    [No Abstract]   [Full Text] [Related]  

  • 14. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method.
    Berberich FR; Berberich MS; King MC; Engleman EG; Grumet FC
    Hum Immunol; 1983 Apr; 6(4):207-17. PubMed ID: 6221004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HLA system in acute leukaemia and Hodgkin's disease.
    Harris R; Lawler SD; Oliver RT
    Br Med Bull; 1978 Sep; 34(3):301-4. PubMed ID: 363226
    [No Abstract]   [Full Text] [Related]  

  • 16. [Familial Hodgkin's disease: a case report and review of the literature].
    Hofer HO; Nagel-Studer E; Nagel GA
    Onkologie; 1979 Jun; 2(3):113-8. PubMed ID: 230435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and susceptibility to Hodgkin's disease.
    Hors J; Dausset J
    Immunol Rev; 1983; 70():167-92. PubMed ID: 6403456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA system antigens in Hodgkin's disease in children].
    Vuković I; Susaković N; Dujić A; Stojimirović E; Marković V
    Bilt Hematol Transfuz; 1977; 5(3-4):59-65. PubMed ID: 615611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated.
    Taylor GM; Gokhale DA; Crowther D; Woll P; Harris M; Alexander F; Jarrett R; Cartwright RA
    Leukemia; 1996 May; 10(5):854-9. PubMed ID: 8656683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.